Directory

>

Claire Neilan

Claire Neilan

Vice President, and Head, Pharmacology and Toxicology | IDEAYA Biosciences

United States

View contact details (it's free)

Claire Neilan

Summary

Claire Neilan is a seasoned Vice President of Preclinical Sciences at IDEAYA Biosciences, bringing over 20 years of experience in the pharmaceutical industry. She is a board-certified toxicologist with a robust background in nonclinical drug development, particularly in oncology. Claire has played a pivotal role in the pharmacology and nonclinical safety testing strategies for a diverse portfolio of small molecule oncology drugs. Her leadership experience includes being the Lead Toxicologist on four marketed products and overseeing approximately 15 IND submissions, showcasing her expertise in regulatory interactions. Claire has held various senior roles at prominent organizations, including Gilead Sciences and Incyte, where she contributed significantly to toxicology and pharmacology. With a PhD in Pharmacology and a BSc in Medicinal and Pharmaceutical Chemistry from Loughborough University, she combines academic excellence with practical industry knowledge. Her career reflects a commitment to advancing drug development and safety, making her a valuable asset in the life sciences sector.

General

Specialist

Technical Background

Leadership Experience

Long-Term Tenure

Professional interests

Industry-specific interests

Emerging Technologies

Leadership Development

Organisational experience

Corporate Experience

Claire Neilan

Work Experience

company logo

Vice President, and Head, Pharmacology and Toxicology at

IDEAYA Biosciences

March 2021 - Present

company logo

Senior Director and Head, Pharmacology and Toxicology at

IDEAYA Biosciences

March 2020 - March 2021

company logo

Senior Director, Preclinical Sciences at

IDEAYA Biosciences

August 2019 - February 2020

company logo

Director, Preclinical Sciences at

IDEAYA Biosciences

November 2017 - July 2019

company logo

Senior Research Scientist, Nonclinical Safety And Pathobiology at

Gilead Sciences Austria

January 2015 - November 2017

company logo

Director, Toxicology at

Incyte

August 2013 - January 2015

company logo

Associate Director, Toxicology at

Incyte

August 2010 - August 2013

company logo

Principal Research Investigator, Toxicology at

Incyte

February 2007 - August 2010

company logo

Senior Research Investigator at

Incyte

February 2004 - February 2007

company logo

Postdoctoral Research Fellow at

Incyte

January 2003 - December 2003

company logo

Research Fellow (post-doc) at

Memorial Sloan Kettering Cancer Center

January 2000 - December 2002

company logo

Visiting Research Student at

University of Michigan Medical Center

May 1997 - December 1999

Logos provided by Logo.dev

Claire Neilan

Education

Loughborough University, Phd

January 1995 - January 2000

Loughborough University, Bsc (Hons)

January 1991 - January 1995

Frequently Asked Questions about Claire Neilan

What is Claire Neilan email address?

Claire Neilan's primary email address is *******@ideayabio.com. To view the full verified email and additional contact details, sign up for free with Muraena.

What company does Claire Neilan work for?

Claire Neilan is a Vice President, and Head, Pharmacology and Toxicology at IDEAYA Biosciences, a company specializing in Commercial physical research.

Where Claire Neilan graduated from?

Claire Neilan holds a degree in Pharmacology from Loughborough University.

How can I directly contact Claire Neilan?

To contact Claire Neilan directly, you can use the email address *******@ideayabio.com. Complete contact information is available upon registration with Muraena.

Who is Claire Neilan?

Claire Neilan is a seasoned Vice President of Preclinical Sciences at IDEAYA Biosciences, bringing over 20 years of experience in the pharmaceutical industry. She is a board-certified toxicologist with a robust background in nonclinical drug development, particularly in oncology. Claire has played a pivotal role in the pharmacology and nonclinical safety testing strategies for a diverse portfolio of small molecule oncology drugs. Her leadership experience includes being the Lead Toxicologist on four marketed products and overseeing approximately 15 IND submissions, showcasing her expertise in regulatory interactions. Claire has held various senior roles at prominent organizations, including Gilead Sciences and Incyte, where she contributed significantly to toxicology and pharmacology. With a PhD in Pharmacology and a BSc in Medicinal and Pharmaceutical Chemistry from Loughborough University, she combines academic excellence with practical industry knowledge. Her career reflects a commitment to advancing drug development and safety, making her a valuable asset in the life sciences sector.

Claire`s contact details

mail

*******@ideayabio.com

Colleagues

avatar
Paul Barsanti

Chief Technology Officer, Head of Drug Discovery

avatar
Mick O'quigley

Senior Vice President, Head of Development Operations

avatar
Mike White

Chief Scientific Officer

Joshua Taygerly

VP and Head of Medicinal Chemistry

avatar
Darrin Beaupre

Chief Medical Officer

avatar
Jasgit Sachdev

Vice President Early Oncology Clinical Development

avatar
Xin Linghu

Vice President, Head of CMC

avatar
Valerie Legagneur

Vice President, Clinical Operations

avatar
Andres Ruiz Briseno

Senior Vice President, Head of Finance and Investor Relations

View Contact details (it's free)
Request Profile Removal